Sigma Planning Corp’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$532K Buy
6,247
+486
+8% +$43.3K 0.01% 803
2025
Q4
$455K Sell
5,761
-166
-3% -$13K 0.01% 828
2025
Q3
$474K Sell
5,927
-808
-12% -$68.9K 0.01% 840
2025
Q2
$612K Sell
6,735
-60
-0.9% -$5.48K 0.02% 697
2025
Q1
$637K Buy
6,795
+839
+14% +$75.1K 0.02% 634
2024
Q4
$541K Sell
5,956
-969
-14% -$92.5K 0.02% 713
2024
Q3
$719K Sell
6,925
-2,795
-29% -$285K 0.02% 606
2024
Q2
$943K Sell
9,720
-634
-6% -$58.5K 0.03% 503
2024
Q1
$932K Buy
10,354
+4,584
+79% +$388K 0.03% 530
2023
Q4
$460K Sell
5,770
-5,596
-49% -$421K 0.04% 480
2023
Q3
$808K Sell
11,366
-433
-4% -$32.4K 0.03% 535
2023
Q2
$909K Sell
11,799
-1,458
-11% -$113K 0.03% 493
2023
Q1
$996K Buy
13,257
+1,498
+13% +$111K 0.03% 514
2022
Q4
$927K Buy
11,759
+1,273
+12% +$95.4K 0.03% 512
2022
Q3
$737K Buy
10,486
+675
+7% +$52.9K 0.03% 572
2022
Q2
$786K Buy
9,811
+159
+2% +$12.4K 0.03% 568
2022
Q1
$732K Sell
9,652
-1,098
-10% -$87K 0.02% 668
2021
Q4
$917K Buy
10,750
+685
+7% +$53.5K 0.03% 585
2021
Q3
$761K Sell
10,065
-2,804
-22% -$223K 0.02% 642
2021
Q2
$1.05M Buy
12,869
+1,473
+13% +$120K 0.03% 541
2021
Q1
$898K Buy
11,396
+2,966
+35% +$232K 0.03% 543
2020
Q4
$721K Sell
8,430
-278
-3% -$23K 0.02% 549
2020
Q3
$672K Buy
8,708
+483
+6% +$36.8K 0.03% 510
2020
Q2
$603K Buy
8,225
+1,671
+25% +$119K 0.03% 529
2020
Q1
$435K Sell
6,554
-1,526
-19% -$108K 0.03% 531
2019
Q4
$556K Buy
8,080
+563
+7% +$38.4K 0.02% 565
2019
Q3
$553K Buy
7,517
+204
+3% +$14.8K 0.03% 545
2019
Q2
$524K Sell
7,313
-359
-5% -$25.5K 0.03% 533
2019
Q1
$526K Sell
7,672
-711
-8% -$45.9K 0.03% 498
2018
Q4
$499K Sell
8,383
-1,068
-11% -$66.8K 0.04% 443
2018
Q3
$633K Buy
9,451
+475
+5% +$31.6K 0.04% 413
2018
Q2
$582K Sell
8,976
-464
-5% -$30.4K 0.04% 414
2018
Q1
$677K Sell
9,440
-1,444
-13% -$104K 0.05% 353
2017
Q4
$821K Buy
10,884
+119
+1% +$8.69K 0.06% 303
2017
Q3
$784K Buy
10,765
+1,836
+21% +$132K 0.06% 311
2017
Q2
$662K Buy
8,929
+1,090
+14% +$80.9K 0.06% 332
2017
Q1
$574K Sell
7,839
-757
-9% -$53K 0.06% 356
2016
Q4
$563K Buy
8,596
+136
+2% +$9.32K 0.06% 320
2016
Q3
$627K Buy
8,460
+654
+8% +$48.3K 0.07% 284
2016
Q2
$571K Buy
7,806
+1,364
+21% +$97.1K 0.07% 288
2016
Q1
$455K Buy
6,442
+1,095
+20% +$72.9K 0.06% 337
2015
Q4
$356K Sell
5,347
-88
-2% -$5.85K 0.05% 401
2015
Q3
$345K Sell
5,435
-425
-7% -$27.8K 0.05% 393
2015
Q2
$383K Sell
5,860
-4,351
-43% -$295K 0.05% 418
2015
Q1
$708K Sell
10,211
-531
-5% -$36.7K 0.09% 257
2014
Q4
$743K Buy
+10,742
New +$725K 0.1% 244

Other funds holding CL

Sigma Planning Corp's CL Position: Q1 2026 in Review

Sigma Planning Corp increased its Colgate-Palmolive (CL) stake by 8.4% in Q1 2026, buying an estimated $43.3K and bringing the position to 6,247 shares worth $532K. The position accounts for 0.01% of the portfolio, ranked #803.

Sigma Planning Corp first reported a position in CL in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.05M in Q2 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Sigma Planning Corp held 6,247 shares of Colgate-Palmolive worth $532K as of Q1 2026.
  • Sigma Planning Corp bought 486 Colgate-Palmolive shares in Q1 2026, an estimated $43.3K.
  • Colgate-Palmolive made up 0.01% of Sigma Planning Corp's portfolio in Q1 2026, its #803 holding.
  • Sigma Planning Corp first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 46 quarters since.
  • Sigma Planning Corp's Colgate-Palmolive position peaked at $1.05M in Q2 2021.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.